These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21134131)

  • 1. On the mechanisms of bananin activity against severe acute respiratory syndrome coronavirus.
    Wang Z; Huang JD; Wong KL; Wang PG; Zhang HJ; Tanner JA; Spiga O; Bernini A; Zheng BJ; Niccolai N
    FEBS J; 2011 Jan; 278(2):383-9. PubMed ID: 21134131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus.
    Tanner JA; Zheng BJ; Zhou J; Watt RM; Jiang JQ; Wong KL; Lin YP; Lu LY; He ML; Kung HF; Kesel AJ; Huang JD
    Chem Biol; 2005 Mar; 12(3):303-11. PubMed ID: 15797214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of novel test compounds for antiviral chemotherapy of severe acute respiratory syndrome (SARS).
    Kesel AJ
    Curr Med Chem; 2005; 12(18):2095-162. PubMed ID: 16101496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single tyrosine in the severe acute respiratory syndrome coronavirus membrane protein cytoplasmic tail is important for efficient interaction with spike protein.
    McBride CE; Machamer CE
    J Virol; 2010 Feb; 84(4):1891-901. PubMed ID: 20007283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a novel coronavirus associated with severe acute respiratory syndrome.
    Rota PA; Oberste MS; Monroe SS; Nix WA; Campagnoli R; Icenogle JP; Peñaranda S; Bankamp B; Maher K; Chen MH; Tong S; Tamin A; Lowe L; Frace M; DeRisi JL; Chen Q; Wang D; Erdman DD; Peret TC; Burns C; Ksiazek TG; Rollin PE; Sanchez A; Liffick S; Holloway B; Limor J; McCaustland K; Olsen-Rasmussen M; Fouchier R; Günther S; Osterhaus AD; Drosten C; Pallansch MA; Anderson LJ; Bellini WJ
    Science; 2003 May; 300(5624):1394-9. PubMed ID: 12730500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overall picture of SARS coronavirus (SARS-CoV) genome-encoded major proteins: structures, functions and drug development.
    Chen S; Luo H; Chen L; Chen J; Shen J; Zhu W; Chen K; Shen X; Jiang H
    Curr Pharm Des; 2006; 12(35):4539-53. PubMed ID: 17168760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase.
    Adedeji AO; Singh K; Calcaterra NE; DeDiego ML; Enjuanes L; Weiss S; Sarafianos SG
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4718-28. PubMed ID: 22733076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
    ter Meulen J; van den Brink EN; Poon LL; Marissen WE; Leung CS; Cox F; Cheung CY; Bakker AQ; Bogaards JA; van Deventer E; Preiser W; Doerr HW; Chow VT; de Kruif J; Peiris JS; Goudsmit J
    PLoS Med; 2006 Jul; 3(7):e237. PubMed ID: 16796401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mosaic evolution of the severe acute respiratory syndrome coronavirus.
    Stavrinides J; Guttman DS
    J Virol; 2004 Jan; 78(1):76-82. PubMed ID: 14671089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments in the virology and antiviral research of severe acute respiratory syndrome coronavirus.
    Yeung KS; Meanwell NA
    Infect Disord Drug Targets; 2007 Mar; 7(1):29-41. PubMed ID: 17346209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Theoretical prediction of the antigenic epitopes of severe acute respiratory syndrome (SARS-CoV) proteins and evaluation of their diagnostic value].
    Ulanova TI; Puzyrev VF; Riabinina SA; Burkov AN; Obriadina AP
    Vopr Virusol; 2005; 50(5):22-4. PubMed ID: 16250594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus.
    Shih YP; Chen CY; Liu SJ; Chen KH; Lee YM; Chao YC; Chen YM
    J Virol; 2006 Nov; 80(21):10315-24. PubMed ID: 17041212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase.
    Lung J; Lin YS; Yang YH; Chou YL; Shu LH; Cheng YC; Liu HT; Wu CY
    J Med Virol; 2020 Jun; 92(6):693-697. PubMed ID: 32167173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytoplasmic tail of the severe acute respiratory syndrome coronavirus spike protein contains a novel endoplasmic reticulum retrieval signal that binds COPI and promotes interaction with membrane protein.
    McBride CE; Li J; Machamer CE
    J Virol; 2007 Mar; 81(5):2418-28. PubMed ID: 17166901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chimeric multi-epitope DNA vaccine elicited specific antibody response against severe acute respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in vitro.
    Wang X; Xu W; Tong D; Ni J; Gao H; Wang Y; Chu Y; Li P; Yang X; Xiong S
    Immunol Lett; 2008 Aug; 119(1-2):71-7. PubMed ID: 18533276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
    Liu YV; Massare MJ; Barnard DL; Kort T; Nathan M; Wang L; Smith G
    Vaccine; 2011 Sep; 29(38):6606-13. PubMed ID: 21762752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural biology. Adaptation of SARS coronavirus to humans.
    Holmes KV
    Science; 2005 Sep; 309(5742):1822-3. PubMed ID: 16166506
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutation analysis of 20 SARS virus genome sequences: evidence for negative selection in replicase ORF1b and spike gene.
    Hu LD; Zheng GY; Jiang HS; Xia Y; Zhang Y; Kong XY
    Acta Pharmacol Sin; 2003 Aug; 24(8):741-5. PubMed ID: 12904271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Genome sequence of the SARS-associated coronavirus.
    Marra MA; Jones SJ; Astell CR; Holt RA; Brooks-Wilson A; Butterfield YS; Khattra J; Asano JK; Barber SA; Chan SY; Cloutier A; Coughlin SM; Freeman D; Girn N; Griffith OL; Leach SR; Mayo M; McDonald H; Montgomery SB; Pandoh PK; Petrescu AS; Robertson AG; Schein JE; Siddiqui A; Smailus DE; Stott JM; Yang GS; Plummer F; Andonov A; Artsob H; Bastien N; Bernard K; Booth TF; Bowness D; Czub M; Drebot M; Fernando L; Flick R; Garbutt M; Gray M; Grolla A; Jones S; Feldmann H; Meyers A; Kabani A; Li Y; Normand S; Stroher U; Tipples GA; Tyler S; Vogrig R; Ward D; Watson B; Brunham RC; Krajden M; Petric M; Skowronski DM; Upton C; Roper RL
    Science; 2003 May; 300(5624):1399-404. PubMed ID: 12730501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.
    Bosch BJ; Martina BE; Van Der Zee R; Lepault J; Haijema BJ; Versluis C; Heck AJ; De Groot R; Osterhaus AD; Rottier PJ
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8455-60. PubMed ID: 15150417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.